Skip to main content
Thursday
May 01, 2025
Sign In
Subscribe
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
THURSDAY,
MAY 01, 2025
Bharat Biotech
Coronavirus chronicle
India launches world’s 1st intranasal Covid vaccine
Coronavirus chronicle
‘Big boost’: Bharat Biotech’s nasal Covid-19 vaccine gets green light
Coronavirus chronicle
Indian drug regulator okays Covaxin for 6-12 year olds, Corbevax for 5-12 bracket
Coronavirus chronicle
India gives nod to Bharat Biotech for intranasal Covid booster doses
Coronavirus chronicle
India's Bharat Biotech says Covaxin booster shot neutralises Omicron
Coronavirus chronicle
Bharat Biotech gets approval to test nasal Covid-19 shot as booster - report
Coronavirus chronicle
Bharat Biotech to produce 1 billion nasal vaccines in 2022
Coronavirus chronicle
Bharat's Covid-19 shot 50% effective at height of India infections - small study
Coronavirus chronicle
India recommends homemade Covid-19 vaccine for kids aged 2 and above
World+Biz
Bharat Biotech says it received no advance payment from Brazil govt for Covaxin
Coronavirus chronicle
Covaxin manufacturing to vaccination takes 4 months, says Bharat Biotech
Coronavirus chronicle
Bharat Biotech submits ‘90% of documents’ for WHO nod
Coronavirus chronicle
India's Bharat Biotech to produce additional 200 mln Covid-19 vaccine doses per year
Show More